摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-t-butyl-[1,3]dithiole-2-thione | 29507-67-3

中文名称
——
中文别名
——
英文名称
4-t-butyl-[1,3]dithiole-2-thione
英文别名
t-butyl-4 dithiole-1,3 thiones-2;4-tert-Butyl-2H-1,3-dithiole-2-thione;4-tert-butyl-1,3-dithiole-2-thione
4-t-butyl-[1,3]dithiole-2-thione化学式
CAS
29507-67-3
化学式
C7H10S3
mdl
——
分子量
190.354
InChiKey
GWXWLOMCKBSQKG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    82.7
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:917df02a3e71a6511d01ebe9684eaa8b
查看

反应信息

  • 作为反应物:
    描述:
    4-t-butyl-[1,3]dithiole-2-thione1-(二乙氨基)丙炔 以 xylene 为溶剂, 以73%的产率得到N,N-diethyl (t-butyl-4 dithiole-1,3 ylidene-2)-2 thiopropionamide
    参考文献:
    名称:
    Dibo, Ahamada; Stavaux, Madeleine; Lozac'H, Noel, Bulletin de la Societe Chimique de France, 1983, vol. 2, # 9-10, p. 277 - 280
    摘要:
    DOI:
  • 作为产物:
    描述:
    硫代氯甲酸苯酯3,3-dimethyl-1,2-bis-triisopropylsilanylsulfanyl-but-1-ene四丁基氟化铵 作用下, 以 四氢呋喃甲苯 为溶剂, 以85%的产率得到4-t-butyl-[1,3]dithiole-2-thione
    参考文献:
    名称:
    Preparation and reactivity studies of 1,2-bis-triisopropylsilanylsulfanyl-alkenes
    摘要:
    The cross-coupling reaction of bis-triisopropylsilyl disulfide 1 on alkynes yielded 1,2-bis-triisopropylsilanylsulfanyl-alkenes 2, a new chemical class. A series of tri and tetrasubstituted olefins 2 were prepared and their behavior toward electrophiles was studied. The triisopropylsilyl groups could be readily removed by treatment with TBAF at 0 degreesC for 1 h or cesium acetate at 70 degreesC for 2 h. Soft and hard electrophiles were submitted to 2 under these conditions. The electrophiles can either react to yield double addition products with alkyl and activated halides, epoxides and acyl chlorides or cyclic adducts with chloroformate derivatives. In the latter case, 1,3-dithiol-2-ones or 1,3-dithiol-2-thiones are prepared. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(01)00517-8
点击查看最新优质反应信息

文献信息

  • DIBO, A.;STAVAUX, M.;LOZACH, N., BULL. SOC. CHIM. FR., 1983, N 9-10, II-277-II-280
    作者:DIBO, A.、STAVAUX, M.、LOZACH, N.
    DOI:——
    日期:——
  • BENITEZ F. M.; GRUNWELL J. R., J. ORG. CHEM., 1978, 43, NO 14, 2917-2918
    作者:BENITEZ F. M.、 GRUNWELL J. R.
    DOI:——
    日期:——
  • CAMPTOTHECIN DRUG COMBINATIONS AND MEDICAMENTS WITH REDUCED SIDE EFFECTS
    申请人:ARCH DEVELOPMENT CORPORATION
    公开号:EP0768895A1
    公开(公告)日:1997-04-23
  • [EN] CAMPTOTHECIN DRUG COMBINATIONS AND MEDICAMENTS WITH REDUCED SIDE EFFECTS<br/>[FR] COMBINAISONS MEDICAMENTEUSE CONTENANT DES CAMPTOTHECINES ET MEDICAMENTS A EFFETS SECONDAIRES REDUITS
    申请人:ARCH DEVELOPMENT CORPORATION
    公开号:WO1996001127A1
    公开(公告)日:1996-01-18
    (EN) This invention provides methods and combination formulations and kits to reduce the toxicity of camptothecin drugs, such as irinotecan (CPT-11). Disclosed are therapeutics and treatment methods employing such drugs in combination with agents that increase conjugative enzyme activity or glucuronosyltransferase activity, and agents that decrease biliary transport protein activity, such as cyclosporine A, the resultant effects of which are to decrease the significant side effects previously associated with treatment using these drugs.(FR) L'invention concerne des procédés, des formulation combinées et des kits permettant de réduire la toxicité de médicaments à la camptothécine tels que l'irinotécan (CTP-11). Elle porte également sur des procédés thérapeutiques et curatifs dans lesquels ces médicaments sont utilisés conjointement avec des agents augmentant l'activité enzymatique de conjugaison ou l'activité glucuronosyltransférase, et des agents réduisant l'activité protéique de transport biliaire tels que la cyclosporine A, ce qui a pour résultat de réduire les effets secondaires sensibles associés auparavant au traitement par ces médicaments.
  • US2023/125778
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多